Navigation Links
Natural Alternatives International, Inc. Announces Carnosyn(R) Beta-Alanine Licensing Agreement
Date:3/9/2009

SAN MARCOS, Calif., March 9 /PRNewswire-FirstCall/ --Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator and manufacturer of customized nutritional supplements, and Compound Solutions, Inc. ("CSI"), a science and marketing based distributor of raw materials to the sports nutrition, dietary supplement, food, pharmaceutical and personal care industries, today jointly announced their licensing agreement of the patented Carnosyn(R) beta-alanine to further develop its use in the dynamic human performance product market. CSI is an importer and distributor of bulk beta-alanine. Under the license agreement, CSI's customers will receive a sublicense of certain of NAI's rights to the use, manufacture and sale of products incorporating the patented Carnosyn(R) beta-alanine. CSI will continue to work with manufacturers of human performance products to drive sales of products with the addition of Carnosyn(R) beta-alanine. NAI also plans to focus on the development and production of all types of dosage form products using Carnosyn(R). Tablets, two piece capsules and powders in many types of packaging are expected to be formulated and manufactured at NAI's certified manufacturing facilities in both Vista, CA and Lugano, Switzerland.

Barry Titlow, Chief Executive Officer of CSI, stated: "We are very excited about our relationship with NAI. We believe the science behind Carnosyn(R) is so well documented our clients will be able to reference the studies with total confidence. We intend to continue to ensure superior quality of the bulk beta-alanine and the continuity of the supply chain. We are inspired by the products now on the market that contain Carnosyn(R) and look forward to the future development of this market."

Mark LeDoux, Chief Executive Officer of NAI added: "We are very pleased to announce this affiliation because of our longstanding relationship with Barry Titlow and CSI. We plan to aggressively defend our patent estate associated with Carnosyn(R) beta-alanine, which we believe is based on unsurpassed scientific and intellectual effort and represents a dynamic estate of intellectual property deserving of commercialization without interference. We believe Carnosyn(R) beta-alanine is truly a breakthrough in performance nutrition. It lends itself well to presentations to consumers in capsule, tablet and compounded form with all sorts of supplement ingredients. We believe there is a large and growing marketplace for Carnosyn(R) beta-alanine and are ready to assist those willing to use the benefits of the patent estate in a lawful manner."

The recognition of beta-alanine by athletes of all levels has been underscored by increasing sales of performance products containing Carnosyn(R) beta-alanine. Controlled studies have demonstrated that carnosine is a highly effective buffer to slow the acidic buildup in exercise stressed muscle, which otherwise could lead to shortened workouts and non-optimal competitive performance. Carnosine synthesis in the body is limited by the availability of beta-alanine. As confirmed in multiple studies, orally delivered Carnosyn(R) beta-alanine increases muscle tissue levels of carnosine, to provide cellular buffering for significant performance and recovery improvement.

CSI is a unique science and marketing based distributor of fine chemicals known for its concept development and global scope. CSI provides raw materials from highly qualified manufacturers to the sports nutrition, dietary supplement, food, pharmaceutical and personal care industries. CSI is involved from concept presentation, to process and dosage improvements, to marketing programs for its clients.

NAI, headquartered in San Marcos, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. Our comprehensive partnership approach offers a wide range of innovative nutritional products and services to our clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see our website at http://www.nai-online.com.

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our expectations and beliefs with respect to our future financial and operating results, including the amount of our future revenue and profits and our future financial condition, and our ability, as well as that of CSI, to further develop, commercialize, market, sell and manufacture Carnosyn(R) beta-alanine, to successfully defend our intellectual property rights in Carnosyn(R) beta-alanine, and to maintain the quality and continuity of the supply of beta-alanine, as well as future market conditions related to and acceptance of Carnosyn(R) beta-alanine, economic conditions and the impact of such conditions on our business. We wish to caution readers these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI's financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q.

CONTACT - Kenneth Wolf, Chief Financial Officer, Natural Alternatives International, Inc., at 760-736-7700 or investor@nai-online.com.

Web site: http://www.nai-online.com/


'/>"/>
SOURCE Natural Alternatives International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Scientists Develop Natural Protection for Stored Foods
2. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
3. SIV infection of natural hosts provides new insights into HIV disease complexity
4. Big Relief for Tiny Itch Mites Found in All Natural Spray Remedy
5. Natural aorta grafts have few side effects for infection-prone patients
6. Fitness Champion Natalie Waples to be Spokesperson for Natural Nutrition International Direct Marketing Campaign
7. New Herbal Water Creating Taste Sensation: Ayalas Herbal Water Has No Calories, No Preservatives and No Artificial Additives. Just All the Natural Benefits of Herbs!
8. Natural Protein Could Help Spot, Treat Liver Cancer
9. The Village Company Unveils Natural Bath and Body Solutions for Everyday Ailments
10. All-Natural Organic Yerba Mate and Organic Aloe Vera Exfoliating Soaps will Help Save Your Skin(TM)
11. New Nutraceutical That Stabilizes Blood Sugar Naturally is Introduced
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on ... Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ability ... fumigation is not a common occurrence, but a necessary one in the event that lice ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... ... 2016 , ... Strategic Capital Partners, LLC (SCP) in concert ... capital for emerging technology companies. SCP has delivered investment events and professional ... than a million dollars of capital investment for five companies. The ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... , June 23, 2016  MedSource announced today ... its e-clinical software solution of choice.  This latest ... possible value to their clients by offering a ... preferred relationship establishes nowEDC as the EDC platform ... MedSource,s full-service clients.  "nowEDC has long been a ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology: